Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05971446 · ClinicalTrials.gov registry record

Healthy Little Eyes

A clinical trial of Hypoxic Ischemic Encephalopathy and Encephalopathy, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
125
Enrollment target
1
Study location

NCT05971446 is a study of Hypoxic Ischemic Encephalopathy and Encephalopathy that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 125 participants, above the 73-participant average among 13 other Hypoxic Ischemic Encephalopathy trials with a reported enrollment target (71% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05971446, a study of Hypoxic Ischemic Encephalopathy and Encephalopathy, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
125 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to gather more information on how eye injury is related to a baby's future development and see if eye function and brain test results can be used, along with current measures, to better diagnose and treat babies with hypoxic-ischemic encephalopathy (HIE). Participants will undergo up to two eye exam sessions, involving both Visual Evoked Potential (VEP) and Electroretinogram (ERG) exams.

Interventions

  • DEVICE Visual Evoked Potential (VEP)
  • DEVICE Electroretinogram (ERG)

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2020-02-24
Est. Completion 2029-07

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT05971446

The ClinicalTrials.gov registry entry for NCT05971446 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 73-participant average among 13 other Hypoxic Ischemic Encephalopathy trials with a reported enrollment target (71% higher). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypoxic Ischemic Encephalopathy appearing as the primary indexed condition, and to 2 interventions - of which Visual Evoked Potential (VEP) is the first listed.

NCT05971446 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05971446 about?

NCT05971446 is a clinical study titled "Healthy Little Eyes". The purpose of this research study is to gather more information on how eye injury is related to a baby's future development and see if eye function and brain test results can be used, along with current measures, to better diagnose and treat babies with hypoxic-ischemic encephalopathy (HIE). Parti...

What is the current status of trial NCT05971446?

This trial is currently recruiting. The enrollment target is 125 participants. The study started on 2020-02-24. Estimated completion is 2029-07.

What conditions does trial NCT05971446 study?

This clinical trial studies the following conditions: Hypoxic Ischemic Encephalopathy, Encephalopathy, Neonatal Encephalopathy.

What interventions are being tested in trial NCT05971446?

The interventions under investigation include: Visual Evoked Potential (VEP) (DEVICE), Electroretinogram (ERG) (DEVICE).

Who is sponsoring clinical trial NCT05971446?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05971446 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxic Ischemic Encephalopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.